Author

Bradley Clinansmith

Observed institution: University of Miami

OpenAlex ID: A5095369293

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

2021 · Wesley H. Self, Mark W. Tenforde, et al. · MMWR Morbidity and Mortality Weekly Report · 406

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

2021 · Mark W. Tenforde, Wesley H. Self, et al. · MMWR Morbidity and Mortality Weekly Report · 204

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021

2021 · Tamara Pilishvili, Katherine E. Fleming-Dutra, et al. · MMWR Morbidity and Mortality Weekly Report · 191

Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021

2021 · Nathaniel M Lewis, Eric A Naioti, et al. · The Journal of Infectious Diseases · 21

Race, Ethnicity, and Delayed Time to COVID-19 Testing Among US Health Care Workers

2024 · DaMarcus E. Baymon, J. Priyanka Vakkalanka, et al. · JAMA Network Open · 7

Works count: 5

Citation count: 829

H-index: 5

I10-index: 4